Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ. Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management. Am J Gastroenterol. 2017;112(10):1509–25. https://doi.org/10.1038/ajg.2017.212.
2. Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019. J Natl Compr Canc Netw. 2019;17(9):1032–41. https://doi.org/10.6004/jnccn.2019.0044.
3. Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2):223–63. https://doi.org/10.1038/ajg.2014.435.
4. Gammon A, Jasperson K, Kohlmann W, Burt RW. Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol. 2009;23(2):219–31. https://doi.org/10.1016/j.bpg.2009.02.007.
5. • National Comprehensive Cancer Network. Genetic/familial high-risk assessment: colorectal (Version 1.2021). 2021. https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf. Accessed June 15, 2021. Recent NCCN guidelines for the evaluation and management of patients with high-risk colorectal cancer syndromes.